The Effect of Intravenous Vitamin C Infusion on Periprocedural Myocardial Injury for Patients Undergoing Elective Percutaneous Coronary Intervention

Slides:

Advertisements

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Advertisements

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis Zhe Xu, MD, PhD, Jin Fan, MD,

Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence David D. Waters, MD, Sripal Bangalore, MD,

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Mortality Related to Periprocedural MI in CTO-PCI

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Totally thoracoscopic repair of atrial septal defect without robotic assistance: A single- center experience Zeng-Shan Ma, MD, PhD, Ming-Feng Dong, MD,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate Szu-Yuan Li, MD, Chiao-Lin Chuang, MD,

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Etiologic features of newly diagnosed epilepsy: Hospital-based study of 892 consecutive patients in West China Yang Si, Ling Liu, Jia Hu, Jie Mu, Jia-jia.

Jin H. Han, MD, Abhinav Chandra, MD, Jyotsna Mulgund, MS, Matthew T

Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,

Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With.

Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System Saba.

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice? Yang Liu,

Comparative Evaluation of 2-Hour Rapid Diagnostic Algorithms for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T Andrew D. McRae,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery Brian T. Bateman,

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Ostial left main coronary artery stenosis as an additional risk factor in off-pump coronary artery bypass grafting Hui-Li Gan, MD, PhD, Jian-Qun Zhang,

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Systematizing Inpatient Referral to Cardiac Rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society Joint.

Spontaneous Coronary Artery Dissection and Fibromuscular Dysplasia

Multilevel data analysis: What? Why? How?

Podocyte Lesions in Patients With Obesity-Related Glomerulopathy

Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass.

Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve.

Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.

Symptoms of Disturbed Sleep Predict Major Adverse Cardiac Events After Percutaneous Coronary Intervention Nisha M. Fernandes, MD, Lynne E. Nield, MD,

For everything there is a season

Perioperative cardiac events in endovascular repair of complex aortic aneurysms and association with preoperative studies Guilherme L. Bub, MD, Roy K.

Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease Neuza Helena Lopes, MD, PhD, Felipe da Silva Paulitsch, MD,

Michel Carrier, MD, Michel Pellerin, MD, Louis P Perrault, MD, PhD, B

Volume 85, Issue 5, Pages (May 2014)

Successful Use of Ranolazine in a Patient With Vasospastic Angina

Shengshou Hu, MD, Xin Yuan, MD, PhD

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

E. -H. Lee, H. -M. Lee, C. -H. Chung, J. -H. Chin, D. -K. Choi, H. -J

CLINICAL OUTCOMES OF TREATMENT BY PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.

From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: A comparison study with off-pump coronary artery bypass.

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

COMPARISON OF OUTCOMES FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN ONTARIO AS REPORTED BY THE CARDIAC CARE.

135 The Association Between Patterns of Myocardial Involvement and Clinical Presentation in Patients With Cardiac Sarcoidosis As Assessed By FDG-PET

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization Philippe Kolh, MD, PhD, Paul Kurlansky,

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Mobile Medicine: Digital Dynamo or Virtual Vaporware

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Presentation transcript:

The Effect of Intravenous Vitamin C Infusion on Periprocedural Myocardial Injury for Patients Undergoing Elective Percutaneous Coronary Intervention Zhi Jian Wang, MD, Wen Kun Hu, MD, Yu Yang Liu, MD, Dong Mei Shi, MD, Wan Jun Cheng, MD, Yong He Guo, MD, Qing Yang, MD, Ying Xin Zhao, MD, Yu Jie Zhou, MD, PhD Canadian Journal of Cardiology Volume 30, Issue 1, Pages 96-101 (January 2014) DOI: 10.1016/j.cjca.2013.08.018 Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Flow chart of patient enrollment. CABG, coronary artery bypass grafting; CK-MB, creatine kinase-MB; c-TNI, cardiac troponin I; eGFR, estimated glomerular filtration rate; PCI, percutaneous coronary intervention. Canadian Journal of Cardiology 2014 30, 96-101DOI: (10.1016/j.cjca.2013.08.018) Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions

Figure 2 Percentages of patients in vitamin C group and control group defined by a range of biomarker ratios for creatine kinase-MB (A) and troponin I (B). ULN, upper limit of normal. Canadian Journal of Cardiology 2014 30, 96-101DOI: (10.1016/j.cjca.2013.08.018) Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions

Figure 3 Changes of serum level of 8-hydroxy-2-deoxyguanosine before and after percutaneous coronary intervention in vitamin C group (A) and control group (B). Canadian Journal of Cardiology 2014 30, 96-101DOI: (10.1016/j.cjca.2013.08.018) Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions